BANK OF MONTREAL /CAN/ - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 57 filers reported holding SECOND SIGHT MED PRODS INC in Q3 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2017$1,0003800.0%0.00%
Q3 2017$03800.0%0.00%
Q2 2017$03800.0%0.00%
Q1 2017$0
-100.0%
380
-23.5%
0.00%
Q4 2016$1,000
-88.9%
497
-79.4%
0.00%
Q3 2016$9,000
-92.4%
2,417
-92.7%
0.00%
Q2 2016$118,000
+11700.0%
33,037
+13665.4%
0.00%
Q4 2015$1,000
-98.4%
240
-95.2%
0.00%
Q1 2015$64,0005,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q3 2016
NameSharesValueWeighting ↓
BOLTON LP 97,500$1,327,0000.37%
BOLTON LP 96,300$1,311,0000.37%
ORACLE INVESTMENT MANAGEMENT INC 210,000$2,859,0000.35%
CARL DOMINO INC 25,295$344,0000.23%
Harvest Capital Strategies LLC 45,000$612,0000.08%
Granite Investment Partners, LLC 49,054$668,0000.06%
FIDUCIARY TRUST INTERNATIONAL LLC 14,100$192,0000.06%
THOMPSON DAVIS & CO., INC. 2,625$36,0000.04%
SOUTH GEORGIA CAPITAL, LLC 750$10,0000.02%
Tower Research Capital LLC (TRC) 8,025$110,0000.01%
View complete list of SECOND SIGHT MED PRODS INC shareholders